Saturday, November 21, 2009 
|
|
|
| subscribe | manage account |
San Diego’s Top Influentials highlights the Who’s Who in San Diego business, profiling the top newsmakers of 2008. This year we focus on the leaders in Biotech, Tech & Defense; Construction; Finance; Law and Business & Consumer Services; and Real Estate.
Since 1886, The Daily Transcript has seen and reported on many significant changes to San Diego’s economic landscape, many of which stem from the remarkable ideas and contributions of individuals. We pay tribute to these prominent newsmakers — San Diego’s movers and shakers — with a special salute to the Top Influentials.
Since 1886, The Daily Transcript has seen and reported on many significant changes to San Diego’s economic landscape, many of which stem from the remarkable ideas and numerous contributions of single individuals. These individuals have impacted our lives, our communities, our economy. Now, we pay tribute to these prominent newsmakers – San Diego’s movers and shakers – with a special salute to the 120 Top Influentials.
As The Daily Transcript celebrates its 120th year in print, our editorial board -- with help from the San Diego Historical Society -- reflects back on our region’s rich history. In this feature, we pay tribute to some of the pioneers who played an integral part in laying the foundation for San Diego’s future growth. Read more about the contributions these individuals have made as the Transcript takes a brief look back through time.
In celebration of The Daily Transcript's 120th Anniversary, we pay tribute to the prominent business leaders -- past and present -- who have impacted the region. The Daily Transcript thanks its sponsors for participating in this anniversary publication.
1600 Faraday Ave.
Carlsbad, CA 92008
Invitrogen is one of the true California garage startups. From its embryonic beginnings, today it is one of the largest biotech tools and technology companies in the world, with annual revenues of $1.2 billion and more than 25,000 products that aid in drug discovery, biodefense, stem cell research and other critical scientific areas.
Under Greg Lucier's leadership, Invitrogen has grown through fast innovation in developing technologies that researchers need next to answer vital questions.
His team's main focus is to develop all the tools, technologies and services needed to develop the next generation of biologically based pharmaceuticals. Lucier has spearheaded a business model that has hundreds of salespeople working in a consultative fashion with their customers. Salespeople are constantly talking about the research taking place, an important element in Invitrogen's success.